A recent independent study of nearly 9,200 patients in Scandinavia and the United States has shown that Merck & Co.’s blood-pressure medication Cozaar is markedly better than the older, more widely prescribed drug atenolol at preventing strokes and diabetes in patients with high blood pressure.
Related Results
CozaarCozaar Sales.Cozaar hypertension indicationFDA gives Cozaar new indicationTeva Announces Tentative Approval for Generic Cozaar Tablets
Atenolol, sold under the brand name Tenormin (AstraZeneca Pharmaceuticals LP), is a beta blocker. ativan. Cozaar blocks an enzyme called angiotensin II. While the two drugs were found to be equally effective in lowering high blood pressure, the study done by Sweden’s Goteborg University found that patients taking Cozaar had a 25% lower risk of stroke and developing diabetes.
COPYRIGHT 2002 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning